AbbVie (ABBV) Asset Utilization Ratio (2013 - 2026)

AbbVie (ABBV) reported Asset Utilization Ratio of 0.46 for Q1 2026, up 9.87% year-over-year from 0.42 in Q1 2025, and up 1.74% quarter-over-quarter from 0.46 in Q4 2025.

AbbVie (ABBV) Asset Utilization Ratio (2013 - 2026) Analysis & Trends

AbbVie (ABBV) has 14 years of Asset Utilization Ratio data on file, last reported at 0.46 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.46, up 9.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (up 9.87% YoY), and the FY2025 annual result was 0.45, up 8.87% from the prior year.
  • Asset Utilization Ratio grew to 0.46 in Q1 2026 per ABBV's latest filing, from 0.46 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.46 in Q1 2026 and troughed at 0.38 in Q2 2024.
  • A 5-year average of 0.41 and a median of 0.41 in 2022 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio rose 17.43% in 2022, then fell 8.88% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.41 in 2022, then declined by 3.26% to 0.4 in 2023, then grew by 0.86% to 0.4 in 2024, then advanced by 12.91% to 0.46 in 2025, then increased by 1.74% to 0.46 in 2026.
  • Business Quant data shows ABBV's Asset Utilization Ratio at 0.46 in Q1 2026, 0.46 in Q4 2025, and 0.44 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 0.53
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.63
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 0.48
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.46
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.50
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.41
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.52
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 0.12
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 0.55
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.46
Dec 31, 2025 0.46
Sep 30, 2025 0.44
Jun 30, 2025 0.43
Mar 31, 2025 0.42
Dec 31, 2024 0.40
Sep 30, 2024 0.39
Jun 30, 2024 0.38
Mar 31, 2024 0.38
Dec 31, 2023 0.40
Sep 30, 2023 0.41
Jun 30, 2023 0.42
Mar 31, 2023 0.42
Dec 31, 2022 0.41
Sep 30, 2022 0.41
Jun 30, 2022 0.40
Mar 31, 2022 0.39
Dec 31, 2021 0.38
Sep 30, 2021 0.37
Jun 30, 2021 0.36